Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Share this article
Open Access Highly Access

Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis

Manuela Rossol*, Matthias Pierer, Sybille Arnold, Gernot Keyßer, Harald Burkhardt, Christoph Baerwald and Ulf Wagner

Arthritis Research & Therapy 2009, 11:R91 doi:10.1186/ar2733

Accesses  

  • Last 30 days: 61 accesses
  • Last 365 days: 567 accesses
  • All time: 9641 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial

Dona L Fleishaker, Juan A Garcia Meijide, Andriy Petrov, Michael Kohen, Xin Wang, Sujatha Menon, Thomas C Stock, Charles A Mebus, James M Goodrich, Howard B Mayer, Bernhardt G Zeiher Arthritis Research & Therapy 2012, 14:R11 (17 January 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations